---

Investigation of effect of ellagic acid on premature ovarian insufficiency

---

Original Article

Author Details : Vinay Vishnudas Sarode*, Sadhna P. Gautam

Volume : 11, Issue : 1, Year : 2024

Article Page : 29-37

https://doi.org/10.18231/j.ijpp.2024.006

Suggest article by email

Get Permission

---

Abstract

Background: One common medical condition affecting the reproductive system in older women is premature ovarian failure (POF). POF can result from radiation therapy, chemotherapy, immune system problems, infection, inflammation, and genetic mutation.
Aim: The current study examined the effect of Ellagic acid on Premature Ovarian Insufficiency.
The study utilized, 8-12 months old 150 ± 20 gm, 42 female wistar rats. For the induction of Premature Ovarian Insufficiency, Tripterygium Glycoside (TG) was administered at a dosage of 50 mg/ml dissolved in water for injection once daily. Clomiphene Citrate, 1 mg/kg was administered orally once daily for 21 days. Ellagic acid was given orally once daily at concentration of 10 mg/kg, 20 mg/kg, 30 mg/kg. The statistic of the data was determined by using ANOVA test.
Results: The results showed that effect of Ellagic acid on premature ovarian insufficiency as evidenced by decreased levels of cholesterol, triglycerides, follicle stimulating hormone and Luteinizing hormone and increased levels of estrogen.
Conclusions: According to the current study, female wistar rats with Tripterygium Glycoside induced Premature Ovarian Insufficiency can benefit from treatment with an Ellagic acid.

Keywords: Ellagic acid, Premature Ovarian Insufficiency, Tripterygium Glycoside, Clomiphene Citrate, ANOVA

How to cite : Sarode V V, Gautam S P, Investigation of effect of ellagic acid on premature ovarian insufficiency. Indian J Pharm Pharmacol 2024;11(1):29-37

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.